The FDA approved the FineVision HP trifocal IOL for use in premium cataract surgery, according to a press release from BVI ...

The intraocular lens market was worth $4.6 billion worldwide in 2024 and is projected to reach $5.6 billion by 2034.

VIENNA — The Duet procedure, in which a monofocal or monofocal toric IOL is implanted into the capsular bag and an additive trifocal IOL is implanted into the sulcus, showed stable long-term outcomes ...

BVI announced today that the FDA approved its FineVision HP trifocal intraocular lens (IOL) for cataract surgery.

PanOptix, the first and only advanced trifocal lens for U.S. patients undergoing cataract surgery, will be showcased in educational events and clinical data presentations First-ever analyses on IOLs ...

BVI's FineVision HP trifocal IOL, approved by the FDA, enhances the US premium IOL market with advanced optic design for ...

GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens (IOL) for cataract patients ...

“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...